Compare Novavax Inc (NVAX) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Toronto-Dominion Bank — how do they compare? Novavax Inc trades at $7.97 (market cap $1.30B), while Toronto-Dominion Bank trades at $121.35 (market cap $199.91B). The key difference: Toronto-Dominion Bank is far larger — about 153.8× Novavax Inc's market cap, and Toronto-Dominion Bank pays a 2.64% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TD | |
|---|---|---|
Market Cap | $1.30B | $199.91B |
Sector | Health | Financials |
52-Week High | $11.19 | $124.80 |
52-Week Low | $6.22 | $72.85 |
Enterprise Value | $879.40M | — |
Dividend Yield | — | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
